- Home
- WAVE vs GRCE Comparison
WAVE vs GRCE Comparison
Compare WAVE & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- GRCE
- Stock Information
- Founded
- WAVE 2011
- GRCE 2002
- Country
- WAVE Israel
- GRCE United States
- Employees
- WAVE N/A
- GRCE N/A
- Industry
- WAVE Electric Utilities: Central
- GRCE
- Sector
- WAVE Utilities
- GRCE
- Exchange
- WAVE Nasdaq
- GRCE NYSE
- Market Cap
- WAVE 35.0M
- GRCE 32.1M
- IPO Year
- WAVE 2021
- GRCE N/A
- Fundamental
- Price
- WAVE $6.63
- GRCE $2.76
- Analyst Decision
- WAVE Strong Buy
- GRCE Strong Buy
- Analyst Count
- WAVE 1
- GRCE 1
- Target Price
- WAVE $15.00
- GRCE $12.00
- AVG Volume (30 Days)
- WAVE 28.5K
- GRCE 26.7K
- Earning Date
- WAVE 05-08-2025
- GRCE 05-19-2025
- Dividend Yield
- WAVE N/A
- GRCE N/A
- EPS Growth
- WAVE N/A
- GRCE N/A
- EPS
- WAVE N/A
- GRCE N/A
- Revenue
- WAVE $168,000.00
- GRCE N/A
- Revenue This Year
- WAVE $325.00
- GRCE N/A
- Revenue Next Year
- WAVE $85.71
- GRCE N/A
- P/E Ratio
- WAVE N/A
- GRCE N/A
- Revenue Growth
- WAVE N/A
- GRCE N/A
- 52 Week Low
- WAVE $2.20
- GRCE $1.75
- 52 Week High
- WAVE $17.63
- GRCE $4.97
- Technical
- Relative Strength Index (RSI)
- WAVE 52.92
- GRCE N/A
- Support Level
- WAVE $5.90
- GRCE N/A
- Resistance Level
- WAVE $6.79
- GRCE N/A
- Average True Range (ATR)
- WAVE 0.47
- GRCE 0.00
- MACD
- WAVE 0.08
- GRCE 0.00
- Stochastic Oscillator
- WAVE 71.80
- GRCE 0.00
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About GRCE GRACE THERAPEUTICS INC
Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.